Entries by NCCS Staff

The Birth of the Cancer Survivorship Movement and How It Transformed Cancer Care for Millions

/in , ,

Guest Post by Judith L. Pearson Best-Selling Author of From Shadows to Life: A Biography of the Cancer Survivorship Movement “Survivorship has been my passion for three decades, so I might talk your ear off!” When Susie Leigh sent those words in an email to me in the summer of 2017, I had no idea […]

Biden Rescinds Trump Admin Proposal to Limit Medicare Part D Coverage of Drugs in “Six Protected Classes”

/in , , ,

This week, the Biden administration rescinded a Trump administration-proposed plan that would have allowed Medicare Part D plans to limit coverage of some drugs in each of the “six protected classes.” The Trump policy sought to remove the protected classes and allow coverage of only one drug per class, including certain cancer treatments. NCCS has […]

NCCS Recommends That States Allocate COVID-19 Vaccines to Cancer Care Providers

/in , , , , ,

The National Coalition for Cancer Survivorship (NCCS) and the Cancer Leadership Council (CLC) sent a letter to the CDC’s Advisory Committee on Immunization Practices (ACIP) to recommend actions to accelerate the vaccination of cancer survivors, who are at risk of poor outcomes from COVID-19. Cancer patients have been confronted by confusing allocation rules and hard-to-navigate […]

COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD

/in , ,

The National Coalition for Cancer Survivorship (NCCS) hosted a conversation on February 23 about COVID-19 vaccines with cancer control expert and Bloomberg Distinguished Professor at Johns Hopkins University, Otis Brawley, MD. Two COVID-19 vaccines have been approved, with more vaccine candidates on the horizon. What do the vaccines mean for people with a history of […]

NCCS Joins Patient, Disability, and Health Care Organizations to Urge U.S. Supreme Court to Protect Medicaid and Rule Against Work Requirements

/in , , , , , , , ,

Loss of Patient Protections Would Raise Barriers to Health Insurance — Seventeen patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae (“friend-of-the-court”) brief today in the U.S. Court of Appeals for the Fifth Circuit in the case Texas v. United States, citing the devastating impact patients would face should the court uphold the District Court ruling to invalidate the Affordable Care Act (ACA). […]

National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster

/in ,

NOTE: This press release was originally published on the National Quality Forum (NQF) website » FOR IMMEDIATE RELEASE FEB 24, 2021 CONTACT: Proof Strategies 202-478-9326, press@qualityforum.org Washington, DC – Today, NQF announced its 2021 Leadership Consortium roster, welcoming leading healthcare experts from 31 diverse Member organizations to shape 2022 priorities for the quality ecosystem. The […]

NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

/in , , , , , , , , ,

The National Coalition for Cancer Survivorship (NCCS) joined with the Cancer Leadership Council (CLC) in urging Health and Human Services Secretary-Designate Xavier Becerra to protect Medicare beneficiaries’ access to Part D drugs in six protected classes, which include certain cancer treatments. In January, the Centers for Medicare and Medicaid Services (CMS) issued a request for […]

NCCS Urges CDC Committee to Include Cancer Survivors in High-Risk Category for COVID-19 Vaccine Distribution

/in , , , , , , , ,

In a letter to the CDC’s Advisory Committee on Immunization Practices (ACIP), NCCS urged the committee to review the data related to the risks that COVID-19 poses to cancer survivors as they monitor and update the immunization schedule and evaluate states’ flexible use of the schedule. There are serious risks to cancer survivors from infection […]

NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care

/in , , , , , , , ,

The National Coalition for Cancer Survivorship (NCCS) joined other member organizations of the Cancer Leadership Council (CLC) in a letter to Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma, urging “immediate action” by CMS to withdraw an interim final rule that implements a most favored nation (MFN) model in Medicare Part B drug […]

NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients

/in , , , , , , , , ,

The National Coalition for Cancer Survivorship (NCCS) recently submitted comments urging the Department of Health and Human Services (HHS) to withdraw a recent proposed rule that would require the review of HHS rules that are more than 10 years old. If implemented, this proposed rule would automatically eliminate regulations that are 10 years old or […]